Purchases and Sales Made in Q1 2023 in Outlook Therapeutics, Inc. (OTLK)
This table provides information about the institutional ownership of Outlook Therapeutics, Inc. (OTLK) during Q1 2023. The information is specifically focused on institutions that hold shares of Outlook Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-7.98K- 44.51% |
$7.98K - $10.8K
|
9.95K
$17.7K
|
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
SELL
|
- |
-9.07K- 49.86% |
$9.07K - $12.2K
|
9.12K
$16.2K
|
|
|
May 12, 2023
Q1 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-20.9K- 14.09% |
$20.9K - $28.2K
|
127K
$227K
|
|
|
May 11, 2023
Q1 2023
|
Vista Finance, LLC
|
SELL
|
- |
-60K- 21.6% |
$60K - $81K
|
218K
$387K
|
|
|
May 11, 2023
Q1 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-67.1K- 99.64% |
$67.1K - $90.5K
|
245
$436
|
|
|
May 11, 2023
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-117K- 62.13% |
$117K - $157K
|
71K
$126K
|
|
|
May 14, 2024
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-117K- 62.13% |
$117K - $157K
|
71K
$126K
|
|
|
May 12, 2023
Q1 2023
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-180K- 64.78% |
$180K - $243K
|
97.8K
$174K
|